Trader Alert --- STEM
- From: "Vincent" <TraderAlert@xxxxxxxxxxxxxxxx>
- Date: Fri, 30 Jun 2006 17:27:30 GMT
Opened a position in STEM
StemCells, Inc., a biopharmaceutical company, engages in the discovery and
development of adult stem cell therapeutics to treat damage to; or
degeneration of major organ systems, such as the central nervous system,
liver, and pancreas. The company is developing investigational new drug
application, which received FDA approval to use its proprietary human neural
stem cells for the treatment of neuronal ceroid lipofuscinosis, a lysosomal
storage disorder; and received approval from the Institutional Review Board
of the Oregon Health & Science University (OHSU) to begin the Phase I trial
at OHSU Doernbecher Children's Hospital. It has a contract research and
license agreement with NeuroSpheres, Ltd. StemCells was co-founded by David
J. Anderson and Fred H. Gage in 1988. The company was formerly known as
Cellular Transplants, Inc. It changed its name to CytoTherapeutics in 1992
and to StemCells, Inc. in 2000. StemCells is headquartered in Palo Alto,
California.
.
- Follow-Ups:
- Re: Trader Alert --- STEM closed hod
- From: Vincent
- Re: Trader Alert --- STEM closed hod
- Prev by Date: Free Online Classes for Chart Readers
- Next by Date: Re: to andrew on junior gold
- Previous by thread: Free Online Classes for Chart Readers
- Next by thread: Re: Trader Alert --- STEM closed hod
- Index(es):
Relevant Pages
|
